C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/01/2011	US8049066 Methods and means for modulating cellulose biosynthesis in fiber producing plants
11/01/2011	US8049065 Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate)
11/01/2011	US8049064 Method for producing polyunsaturated C20- and C22-fatty acids with at least four double bonds in transgenic plants
11/01/2011	US8049000 Early endosperm promoter eep2
11/01/2011	US8048995 Human skeletal muscle-specific ubiquitin-conjugating enzyme
11/01/2011	US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011	US8048991 Antibody to an integrin heterodimer and/or a subunit thereof
11/01/2011	US8048990 Modified vitamin K-dependent polypeptides
11/01/2011	US8048987 Polypeptides having DNA polymerase activity
11/01/2011	US8048986 Reversed mammalian protein-protein interaction trap
11/01/2011	US8048863 RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
11/01/2011	US8048858 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048844 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2011	US8048675 Integration-free human induced pluripotent stem cells from blood
11/01/2011	US8048674 Methods and compositions for cellular and metabolic engineering
11/01/2011	US8048672 Comprises nucleotide sequences coding transcription factor for treating infections, multiple sclerosis, arthritis and autoimmune disease
11/01/2011	US8048670 Synthetic genes and genetic constructs
11/01/2011	US8048667 Hybrid alpha-glucoside transporter
11/01/2011	US8048665 Nucleotide sequences encoding alanine racemase from coryneform
11/01/2011	US8048664 Polynucleotides encoding modified DNA cleavage enzymes and host cells therefor
11/01/2011	US8048657 Enzyme compositions comprising a glucoamylase, an acid stable alpha amylase, and an acid fungal protease
11/01/2011	US8048653 Microbial oils produced in transformed host cells comprising delta-9 elongases
11/01/2011	US8048651 Methods for the preparation of lysine by fermentation of Corynebacterium glutamicum
11/01/2011	US8048650 Microorganism of Corynebacterium genus having enhanced L-lysine productivity and a method of producing L-lysine using the same
11/01/2011	US8048646 NELL peptide expression systems and bone formation activity of NELL peptide
11/01/2011	US8048645 Preparing fusion protein comprising multiple functional protein domains via homologous recombination
11/01/2011	US8048632 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
11/01/2011	US8048631 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences
11/01/2011	US8048627 Method and compositions for detection and enumeration of genetic variations
11/01/2011	US8048433 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
11/01/2011	US8048428 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
11/01/2011	US8048427 Subgenomic replicons of the flavivirus dengue
11/01/2011	US8048424 Insect poison allergens with reduced IgE reactivity and method for producing the same
11/01/2011	US8048417 Anti-human tenascin monoclonal antibody
11/01/2011	CA2604143C Methods for detecting thyroid carcinoma cells
11/01/2011	CA2595203C An inducible deoxyhypusine synthase promoter from maize
11/01/2011	CA2537880C Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps
11/01/2011	CA2476456C Method to isolate dna
11/01/2011	CA2447602C Anti-trail-r antibodies
11/01/2011	CA2404938C Production of polyketides
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
11/01/2011	CA2400543C The involvement of the bdnf gene in mood disorders
11/01/2011	CA2400338C A molecular library for recognition or detection of a binding site
11/01/2011	CA2379100C Methods for reducing the formation of byproducts in the production of recombinant polypeptides
11/01/2011	CA2376299C Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
11/01/2011	CA2374916C Diagnostics and therapeutics for cardiovascular disorders
11/01/2011	CA2366056C Non-spreading pestivirus
11/01/2011	CA2337967C Recombinant uricase protein
11/01/2011	CA2320073C Method of controlling proliferation and differentiation of stem and progenitor cells
11/01/2011	CA2302992C Methods for generating high titer helper-free preparations of recombinant aav vectors
11/01/2011	CA2295986C Novel antimicrobial polypeptide and methods of use
11/01/2011	CA2245818C Modification of polysaccharides
11/01/2011	CA2235443C Novel insulin derivatives having a rapid onset of action
11/01/2011	CA2224626C Expression system employing a xylanolytic transcriptional activator
11/01/2011	CA2221192C Embedded expression of heterologous proteins
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
11/01/2011	CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide
10/2011
10/27/2011	WO2011133984A2 New bacterium for production of chemicals and recombinants thereof
10/27/2011	WO2011133960A2 Lysosomal storage disease enzyme
10/27/2011	WO2011133952A2 New bacterium for production of chemicals and recombinants thereof
10/27/2011	WO2011133947A2 X-str multiplex system
10/27/2011	WO2011133935A2 Methods and kits for risk assessment of barrett's neoplastic progression
10/27/2011	WO2011133923A1 Modulation of lactosylceramide synthase (lcs) expression
10/27/2011	WO2011133890A1 Cns targeting aav vectors and methods of use thereof
10/27/2011	WO2011133889A2 NOVEL STRUCTURALLY DESIGNED shRNAs
10/27/2011	WO2011133871A2 5'-end derivatives
10/27/2011	WO2011133866A2 Transgenic algae with enhanced oil expression
10/27/2011	WO2011133803A1 Compositions and methods for targeted inactivation of hiv cell surface receptors
10/27/2011	WO2011133802A1 Compositions and methods for treatment of lysosomal storage disorders
10/27/2011	WO2011133704A2 Modified polypeptides and proteins and uses thereof
10/27/2011	WO2011133695A2 Materials and methods for nucleic acid fractionation by solid phase entrapment and enzyme-mediated detachment
10/27/2011	WO2011133658A1 Compositions and methods for targeting and delivering therapeutics into cells
10/27/2011	WO2011133584A2 Nucleic acid compounds for inhibiting hras gene expression and uses thereof
10/27/2011	WO2011133559A2 Alpha tubulin acetyltransferase
10/27/2011	WO2011133512A1 Rtef-1 variants and uses thereof
10/27/2011	WO2011133493A2 Allosteric regulation of kinase activity
10/27/2011	WO2011133387A1 Gene switch compositions and methods of use
10/27/2011	WO2011133284A1 Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof
10/27/2011	WO2011133142A1 Treatment of vhl-negative tumors
10/27/2011	WO2011133112A1 Cell penetrating peptide derived from the premembrane protein of flavivirus
10/27/2011	WO2011133111A1 Trichoderma viride strain for cellulolytic enzyme production
10/27/2011	WO2011133040A2 Replication-competent adenoviruses
10/27/2011	WO2011132990A2 Transgenic cloned canine overexpressing pepck, and production method thereof
10/27/2011	WO2011132989A2 Methylation marker for diagnosis of cervical cancer
10/27/2011	WO2011132977A2 Pcr device including two heating blocks
10/27/2011	WO2011132941A2 Tf-bpb specifically binding to transcription factor
10/27/2011	WO2011132940A2 Rtk-bpb specifically binding to rtk
10/27/2011	WO2011132939A2 Rtk-bpb specifically binding to rtk
10/27/2011	WO2011132938A2 Gpcr-bpb specifically binding to gpcr
10/27/2011	WO2011132890A2 Transformant for enhancing bioethanol production, and method for producing ethanol by using said strain
10/27/2011	WO2011132872A2 Information providing method for diagnosis of tuberculosis, and tuberculosis diagnostic kit for same
10/27/2011	WO2011132854A2 Heterogeneous e. coli for improving fatty acid content using fatty acid biosynthesis and preparation method thereof
10/27/2011	WO2011132852A2 Pseudomonas aeruginosa strain developed for improving fatty acid content, and method of manufacturing the same
10/27/2011	WO2011132836A2 Ethanol-resistant yeast gene, and use thereof
10/27/2011	WO2011132835A2 Ethanol-, heat- or furfural- resistant yeast strain, and gene thereof
10/27/2011	WO2011132830A1 A new kanamycin compound, kanamycin-producing streptomyces species bacterium, and method of producing kanamycin
10/27/2011	WO2011132801A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof
10/27/2011	WO2011132798A1 Novel dna methylation analysis method
10/27/2011	WO2011132726A1 METHOD FOR PREPARING aRNA AND METHOD FOR ASSAYING GENE EXPRESSION

1 ... 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 ... 4023